4CPS-064 Evaluation of broad-spectrum beta-lactam prescriptions (except carbapenems) in the military hospital of instruction mohammed V rabat. (March 2019)
- Record Type:
- Journal Article
- Title:
- 4CPS-064 Evaluation of broad-spectrum beta-lactam prescriptions (except carbapenems) in the military hospital of instruction mohammed V rabat. (March 2019)
- Main Title:
- 4CPS-064 Evaluation of broad-spectrum beta-lactam prescriptions (except carbapenems) in the military hospital of instruction mohammed V rabat
- Authors:
- Moutaouakkil, Y
Tadlaoui, Y
Atbib, Y
Adouani, B
Bennana, A
Cherrah, Y
Lamsaouri, J
Bousliman, Y - Abstract:
- Abstract : Background: The prescription of antibiotics has become one of the most critical acts in hospitals. 1 This is related to the risk of misuse of these drugs and its impact on the development of bacterial resistance and antibiotic inefficiency. Purpose: We aimed to assess broad-spectrum beta-lactam prescriptions (except carbapenems) and the impact of controlled dispensing, antimicrobial management team and antibiotic treatment reassessment in 48–72 hours. Material and methods: This is a descriptive study, which took place on a given day in all hospital units and analysed curative antibiotic broad-spectrum beta-lactam prescriptions. The assessment focused on indication, dosing, combinations, revaluation in 48–72 hours and treatment duration. Results: One-hundred and three prescriptions were identified: amoxicillin (9.70%, n=10), amoxicillin-clavulanic acid (43.69%, n=45), ceftriaxone (33%, n=34), piperacillin-tazobactam (3.88%, n=4), Ceftazidime (7.76%, n=8), and Cefepime (1.94%, n=2). The compliance of the indication, dosage, combinations and re-evaluation at 48–72 hours was satisfactory, respectively 67.96% (n=70), 81.55% (n=84), 82.75% (24/29 associations) and 65.04% (n=67). The compliance of the treatment duration was only 43.68% (n=45). Controlled dispensing showed interest in total antibiotic treatment duration: 76.69% vs. 34.95% compliance for non-controlled dispensed beta-lactams (p=0.02). Conclusion: The prescription or not of broad-spectrum betalactamines isAbstract : Background: The prescription of antibiotics has become one of the most critical acts in hospitals. 1 This is related to the risk of misuse of these drugs and its impact on the development of bacterial resistance and antibiotic inefficiency. Purpose: We aimed to assess broad-spectrum beta-lactam prescriptions (except carbapenems) and the impact of controlled dispensing, antimicrobial management team and antibiotic treatment reassessment in 48–72 hours. Material and methods: This is a descriptive study, which took place on a given day in all hospital units and analysed curative antibiotic broad-spectrum beta-lactam prescriptions. The assessment focused on indication, dosing, combinations, revaluation in 48–72 hours and treatment duration. Results: One-hundred and three prescriptions were identified: amoxicillin (9.70%, n=10), amoxicillin-clavulanic acid (43.69%, n=45), ceftriaxone (33%, n=34), piperacillin-tazobactam (3.88%, n=4), Ceftazidime (7.76%, n=8), and Cefepime (1.94%, n=2). The compliance of the indication, dosage, combinations and re-evaluation at 48–72 hours was satisfactory, respectively 67.96% (n=70), 81.55% (n=84), 82.75% (24/29 associations) and 65.04% (n=67). The compliance of the treatment duration was only 43.68% (n=45). Controlled dispensing showed interest in total antibiotic treatment duration: 76.69% vs. 34.95% compliance for non-controlled dispensed beta-lactams (p=0.02). Conclusion: The prescription or not of broad-spectrum betalactamines is a multifactorial and complex act, but the compliance regarding the duration of treatment could be improved, in particular by a strengthening of the controls of prescriptions. Reference and/or acknowledgements: Didouh M, Cheikh A, Zerhouni MW, et al. Les déterminants de la prescription des antibiotiques à l'hôpital. Revue d'Épidémiol Santé Pub 2018;66:S153. No conflict of interest. … (more)
- Is Part Of:
- European journal of hospital pharmacy. Volume 26(2019)Supplement 1
- Journal:
- European journal of hospital pharmacy
- Issue:
- Volume 26(2019)Supplement 1
- Issue Display:
- Volume 26, Issue 1 (2019)
- Year:
- 2019
- Volume:
- 26
- Issue:
- 1
- Issue Sort Value:
- 2019-0026-0001-0000
- Page Start:
- A97
- Page End:
- A98
- Publication Date:
- 2019-03
- Subjects:
- Pharmacy -- Periodicals
Hospital pharmacies -- Periodicals
615.1 - Journal URLs:
- http://www.bmj.com/archive ↗
http://ejhp.bmj.com/ ↗ - DOI:
- 10.1136/ejhpharm-2019-eahpconf.213 ↗
- Languages:
- English
- ISSNs:
- 2047-9956
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 18766.xml